journal article·2024-12-31Open access

The identification of metabolites from gut microbiota in coronary heart disease via network pharmacology

Hao-Ming Zhou, Xin-Yu Yang, Shi-Jun Yue, Wen-Xiao Wang, Qiao Zhang, Ding-Qiao Xu, Jia-Jia Li, Yu-Ping Tang

Abstract

Although the gut microbial metabolites exhibit potential effects on coronary heart disease (CHD), the underlying mechanism remains unclear. In this study, the active gut microbial metabolites acting on CHD and their potential mechanisms of action were explored through a network pharmacological approach. We collected a total of 208 metabolites from the gutMgene database and 726 overlapping targets from the similarity ensemble approach (SEA) and SwissTargetPrediction (STP) database, and ultimately identified 610 targets relevant to CHD. In conjunction with the gutMGene database, we identified 12 key targets. The targets of exogenous substances were removed, and 10 core targets involved in CHD were eventually retained. The microbiota-metabolites-targets-signalling pathways network analysis revealed that C-type lectin receptor signalling pathway, Lachnospiraceae, Escherichia, mitogen-activated protein kinase 1, prostaglandin-endoperoxidase synthase 2, phenylacetylglutamine and alcoholic acid are notable components of CHD and play important roles in the development of CHD. The results of molecular docking experiments demonstrated that AKT1-glycocholic acid and PTGS2-phenylacetylglutamine complexes may act on C-type lectin receptor signalling pathways. In this study, the key substances and potential mechanisms of gut microbial metabolites were analysed via network pharmacological methods, and a scientific basis and comprehensive idea were provided for the effects of gut microbial metabolites on CHD.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gut microbiota and health · Metabolomics and Mass Spectrometry Studies · Bioinformatics and Genomic Networks

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Shaanxi University of Chinese Medicine, Xi’an, China

Department of Pharmacy, Beijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

International Joint Research Center on Resource Utilization and Quality Evaluation of Traditional Chinese Medicine of Hebei Province, Hebei University of Chinese Medicine, Shijiazhuang, China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shaanxi Province · Subject Innovation Team of Shaanxi University of Chinese Medicine

References (49)

Show source-provided references
1. 10.1016/j.amjmed.2014.04.01510.1016/j.amjmed.2014.04.015 ↗
2. 10.1093/eurheartj/ehv20610.1093/eurheartj/ehv206 ↗
3. 10.1097/MAJ.0b013e31828aab4510.1097/MAJ.0b013e31828aab45 ↗
4. 10.1016/j.phymed.2018.11.01010.1016/j.phymed.2018.11.010 ↗
5. 10.3390/ijms2017415510.3390/ijms20174155 ↗
6. 10.33549/physiolres.93402210.33549/physiolres.934022 ↗
7. 10.3748/wjg.v21.i29.878710.3748/wjg.v21.i29.8787 ↗
8. 10.1007/s00380-016-0841-y10.1007/s00380-016-0841-y ↗
9. 10.1007/s00018-018-2943-410.1007/s00018-018-2943-4 ↗
10. 10.1093/eurheartj/suaa14910.1093/eurheartj/suaa149 ↗
11. Wang YL, Cheng YL, Shang LH. Research advance in gut microbiota in the pathogenesis of coronary artery disease. Chin Res Hosp. 2022;10(1):59–62.
12. 10.1080/10408363.2018.146350710.1080/10408363.2018.1463507 ↗
13. 10.1016/j.atherosclerosis.2019.11.02610.1016/j.atherosclerosis.2019.11.026 ↗
14. 10.1186/s12967-020-02539-x10.1186/s12967-020-02539-x ↗
15. 10.1038/nrcardio.2017.12010.1038/nrcardio.2017.120 ↗
16. 10.1016/j.redox.2018.02.00710.1016/j.redox.2018.02.007 ↗
17. 10.1016/j.vph.2023.10721010.1016/j.vph.2023.107210 ↗
18. 10.3390/cimb4412041510.3390/cimb44120415 ↗
19. 10.1097/FJC.000000000000138710.1097/FJC.0000000000001387 ↗
20. 10.1038/nchembio.11810.1038/nchembio.118 ↗
21. 10.1038/s41598-023-27885-w10.1038/s41598-023-27885-w ↗
22. 10.1038/nbt128410.1038/nbt1284 ↗
23. 10.1093/bioinformatics/btt54010.1093/bioinformatics/btt540 ↗
24. 10.1002/cmdc.20160018210.1002/cmdc.201600182 ↗
25. 10.1186/s13321-018-0283-x10.1186/s13321-018-0283-x ↗
26. 10.1007/s11684-019-0692-x10.1007/s11684-019-0692-x ↗
27. 10.1016/j.lfs.2006.08.02710.1016/j.lfs.2006.08.027 ↗
28. 10.1002/jcp.2771710.1002/jcp.27717 ↗
29. 10.1002/eji.20164687910.1002/eji.201646879 ↗
30. 10.1155/2017/379635910.1155/2017/3796359 ↗
31. Peng Y, Zhang N, Li WJ, et al. Correlations of changes in inflammatory factors, glucose and lipid metabolism indicators and adiponectin with alterations in intestinal flora in rats with coronary heart disease. Eur Rev Med Pharmacol Sci. 2020;24(19):10118–10125.
32. 10.1016/j.ijcard.2008.04.00910.1016/j.ijcard.2008.04.009 ↗
33. 10.1515/CCLM.2011.02410.1515/CCLM.2011.024 ↗
34. 10.1007/s10456-008-9112-610.1007/s10456-008-9112-6 ↗
35. 10.1093/gastro/goz02810.1093/gastro/goz028 ↗
36. 10.1007/s11655-009-0101-410.1007/s11655-009-0101-4 ↗
37. 10.1016/j.freeradbiomed.2021.05.00910.1016/j.freeradbiomed.2021.05.009 ↗
38. 10.1074/jbc.M00916020010.1074/jbc.M009160200 ↗
39. 10.1038/9060910.1038/90609 ↗
40. 10.1016/j.imbio.2011.08.00510.1016/j.imbio.2011.08.005 ↗
41. 10.1016/j.chemosphere.2019.12507710.1016/j.chemosphere.2019.125077 ↗
42. 10.3389/fcvm.2021.74749710.3389/fcvm.2021.747497 ↗
43. 10.1002/jcb.2872510.1002/jcb.28725 ↗
44. 10.3390/metabo1212116510.3390/metabo12121165 ↗
45. 10.3389/fcimb.2022.90382810.3389/fcimb.2022.903828 ↗
46. 10.1161/JAHA.122.02603610.1161/JAHA.122.026036 ↗
47. Wang CY, Wang M, Jiang H. The correlation between phenylacetylglutamine and atrial fibrillation. Chin J Cardiovasc Res. 2022;20(10):876–880.
48. 10.1016/j.cell.2020.02.01610.1016/j.cell.2020.02.016 ↗
49. 10.1023/A:101281261608310.1023/A:1012812616083 ↗